IGF1 and bacterial infectious disease: daf-2 insulin/IGF-1 signaling (IIS) mutants are long-lived (Kenyon et al., 1993) and exhibit increased resistance to bacterial infection (Garsin et al., 2003; Podshivalova et al., 2017; Troemel et al., 2006; Zhao et al., 2021).